Cargando…
Molecular Characterization and Antifungal Susceptibility of Clinical Fusarium Species From Brazil
Fusarium is widely distributed in the environment and is involved with plant and animal diseases. In humans, several species and species complexes (SC) are related to fusariosis, i.e., F. solani SC, F. oxysporum SC, F. fujikuroi SC, F. dimerum, F. chlamydosporum, F. incarnatum-equiseti, and F. sporo...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467941/ https://www.ncbi.nlm.nih.gov/pubmed/31024507 http://dx.doi.org/10.3389/fmicb.2019.00737 |
_version_ | 1783411331549888512 |
---|---|
author | Herkert, Patricia F. Al-Hatmi, Abdullah M. S. de Oliveira Salvador, Gabriel L. Muro, Marisol D. Pinheiro, Rosângela L. Nucci, Márcio Queiroz-Telles, Flávio de Hoog, G. Sybren Meis, Jacques F. |
author_facet | Herkert, Patricia F. Al-Hatmi, Abdullah M. S. de Oliveira Salvador, Gabriel L. Muro, Marisol D. Pinheiro, Rosângela L. Nucci, Márcio Queiroz-Telles, Flávio de Hoog, G. Sybren Meis, Jacques F. |
author_sort | Herkert, Patricia F. |
collection | PubMed |
description | Fusarium is widely distributed in the environment and is involved with plant and animal diseases. In humans, several species and species complexes (SC) are related to fusariosis, i.e., F. solani SC, F. oxysporum SC, F. fujikuroi SC, F. dimerum, F. chlamydosporum, F. incarnatum-equiseti, and F. sporotrichoides. We aimed to investigate the susceptibility of Fusarium clinical isolates to antifungals and azole fungicides and identify the species. Forty-three clinical Fusarium isolates were identified by sequencing translation elongation factor 1-alpha (TEF1α) gene. Antifungal susceptibility testing was performed to the antifungals amphotericin B, itraconazole, voriconazole, posaconazole, and isavuconazole, and the azole fungicides difenoconazole, tebuconazole, and propiconazole. The isolates were recovered from patients with median age of 36 years (range 2–78 years) of which 21 were female. Disseminated fusariosis was the most frequent clinical form (n = 16, 37.2%) and acute lymphoblastic leukemia (n = 7; 16.3%) was the most commonly underlying condition. A few species described in Fusarium solani SC have recently been renamed in the genus Neocosmospora, but consistent naming is yet not possible. Fusarium keratoplasticum FSSC 2 (n = 12) was the prevalent species, followed by F. petroliphilum FSSC 1 (n = 10), N. gamsii FSSC 7 (n = 5), N. suttoniana FSSC 20 (n = 3), F. solani sensu stricto FSSC 5 (n = 2), Fusarium sp. FSSC 25 (n = 2), Fusarium sp. FSSC 35 (n = 1), Fusarium sp. FSSC18 (n = 1), F. falciforme FSSC 3+4 (n = 1), F. pseudensiforme (n = 1), and F. solani f. xanthoxyli (n = 1). Amphotericin B had activity against most isolates although MICs ranged from 0.5 to 32 μg mL(-1). Fusarium keratoplasticum showed high MIC values (8–>32 μg mL(-1)) for itraconazole, voriconazole, posaconazole, and isavuconazole. Among agricultural fungicides, difenoconazole had the lowest activity against FSSC with MICs of >32 μg mL(-1) for all isolates. |
format | Online Article Text |
id | pubmed-6467941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64679412019-04-25 Molecular Characterization and Antifungal Susceptibility of Clinical Fusarium Species From Brazil Herkert, Patricia F. Al-Hatmi, Abdullah M. S. de Oliveira Salvador, Gabriel L. Muro, Marisol D. Pinheiro, Rosângela L. Nucci, Márcio Queiroz-Telles, Flávio de Hoog, G. Sybren Meis, Jacques F. Front Microbiol Microbiology Fusarium is widely distributed in the environment and is involved with plant and animal diseases. In humans, several species and species complexes (SC) are related to fusariosis, i.e., F. solani SC, F. oxysporum SC, F. fujikuroi SC, F. dimerum, F. chlamydosporum, F. incarnatum-equiseti, and F. sporotrichoides. We aimed to investigate the susceptibility of Fusarium clinical isolates to antifungals and azole fungicides and identify the species. Forty-three clinical Fusarium isolates were identified by sequencing translation elongation factor 1-alpha (TEF1α) gene. Antifungal susceptibility testing was performed to the antifungals amphotericin B, itraconazole, voriconazole, posaconazole, and isavuconazole, and the azole fungicides difenoconazole, tebuconazole, and propiconazole. The isolates were recovered from patients with median age of 36 years (range 2–78 years) of which 21 were female. Disseminated fusariosis was the most frequent clinical form (n = 16, 37.2%) and acute lymphoblastic leukemia (n = 7; 16.3%) was the most commonly underlying condition. A few species described in Fusarium solani SC have recently been renamed in the genus Neocosmospora, but consistent naming is yet not possible. Fusarium keratoplasticum FSSC 2 (n = 12) was the prevalent species, followed by F. petroliphilum FSSC 1 (n = 10), N. gamsii FSSC 7 (n = 5), N. suttoniana FSSC 20 (n = 3), F. solani sensu stricto FSSC 5 (n = 2), Fusarium sp. FSSC 25 (n = 2), Fusarium sp. FSSC 35 (n = 1), Fusarium sp. FSSC18 (n = 1), F. falciforme FSSC 3+4 (n = 1), F. pseudensiforme (n = 1), and F. solani f. xanthoxyli (n = 1). Amphotericin B had activity against most isolates although MICs ranged from 0.5 to 32 μg mL(-1). Fusarium keratoplasticum showed high MIC values (8–>32 μg mL(-1)) for itraconazole, voriconazole, posaconazole, and isavuconazole. Among agricultural fungicides, difenoconazole had the lowest activity against FSSC with MICs of >32 μg mL(-1) for all isolates. Frontiers Media S.A. 2019-04-10 /pmc/articles/PMC6467941/ /pubmed/31024507 http://dx.doi.org/10.3389/fmicb.2019.00737 Text en Copyright © 2019 Herkert, Al-Hatmi, de Oliveira Salvador, Muro, Pinheiro, Nucci, Queiroz-Telles, de Hoog and Meis. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Herkert, Patricia F. Al-Hatmi, Abdullah M. S. de Oliveira Salvador, Gabriel L. Muro, Marisol D. Pinheiro, Rosângela L. Nucci, Márcio Queiroz-Telles, Flávio de Hoog, G. Sybren Meis, Jacques F. Molecular Characterization and Antifungal Susceptibility of Clinical Fusarium Species From Brazil |
title | Molecular Characterization and Antifungal Susceptibility of Clinical Fusarium Species From Brazil |
title_full | Molecular Characterization and Antifungal Susceptibility of Clinical Fusarium Species From Brazil |
title_fullStr | Molecular Characterization and Antifungal Susceptibility of Clinical Fusarium Species From Brazil |
title_full_unstemmed | Molecular Characterization and Antifungal Susceptibility of Clinical Fusarium Species From Brazil |
title_short | Molecular Characterization and Antifungal Susceptibility of Clinical Fusarium Species From Brazil |
title_sort | molecular characterization and antifungal susceptibility of clinical fusarium species from brazil |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467941/ https://www.ncbi.nlm.nih.gov/pubmed/31024507 http://dx.doi.org/10.3389/fmicb.2019.00737 |
work_keys_str_mv | AT herkertpatriciaf molecularcharacterizationandantifungalsusceptibilityofclinicalfusariumspeciesfrombrazil AT alhatmiabdullahms molecularcharacterizationandantifungalsusceptibilityofclinicalfusariumspeciesfrombrazil AT deoliveirasalvadorgabriell molecularcharacterizationandantifungalsusceptibilityofclinicalfusariumspeciesfrombrazil AT muromarisold molecularcharacterizationandantifungalsusceptibilityofclinicalfusariumspeciesfrombrazil AT pinheirorosangelal molecularcharacterizationandantifungalsusceptibilityofclinicalfusariumspeciesfrombrazil AT nuccimarcio molecularcharacterizationandantifungalsusceptibilityofclinicalfusariumspeciesfrombrazil AT queiroztellesflavio molecularcharacterizationandantifungalsusceptibilityofclinicalfusariumspeciesfrombrazil AT dehooggsybren molecularcharacterizationandantifungalsusceptibilityofclinicalfusariumspeciesfrombrazil AT meisjacquesf molecularcharacterizationandantifungalsusceptibilityofclinicalfusariumspeciesfrombrazil |